FOR IMMEDIATE RELEASE
Allison Fleming, NYHQ
New York Hospital Queens Earns 5-Diamond Designation from
Island Peer Review Organization End Stage Renal Disease Network of New York
Flushing, N.Y., July 15, 2013 — New York Hospital Queens (NYHQ) announced today that the NYHQ Trude Weishaupt Memorial Satellite Dialysis Center has earned a 5-Diamond Designation from the Island Peer Review Organization (IPRO) End Stage Renal Disease Network of New York. The Network’s 5-Diamond Approach to Patient Safety Program helps dialysis facilities implement patient safety principles among staff and patients.
To earn this designation, NYHQ staff applied five patient safety modules to the center’s practices. The completed modules were on topics that include patient safety principles, hand hygiene, stenosis surveillance, transplantation and venous needle dislodgement. The center’s staff developed the venous needle dislodgement assessment tool that evaluates and scores a patient’s risk for dislodgement and implements preventative measures.
“The center’s excellent clinical outcomes are possible because of our emphasis on patient safety. Our staff is always evaluating ways to improve and build upon patient safety and in this process, we developed a new tool that is now being used by other dialysis facilities in this network,” said Joan Arslanian R.N., F.N.P., clinical director, Trude Weishaupt Memorial Satellite Dialysis Center.
The Trude Weishaupt Memorial Satellite Dialysis Center has offered high quality treatment for patients with kidney disease for more than 37 years. The center is located at 59-28 174th Street in Fresh Meadows. Members of the community interested in more information about the center can call (718) 670-1276.
New York Hospital Queens is a member of the NewYork-Presbyterian Healthcare System and is affiliated with Weill Medical College of Cornell University. For more information on New York Hospital Queens, visit www.nyhq.org.
# # #